Latest Capital Markets News

Podium Minerals has announced a major metallurgical breakthrough with a new concentrator flowsheet achieving approximately 80% recovery of key platinum group metals, advancing its Parks Reef Project towards commercialisation.

Judo Bank has successfully priced a $150 million Tier 2 subordinated notes issuance with a significantly tighter margin, reflecting its strengthened credit profile and strong investor demand.

EMVision Medical Devices has launched a Share Purchase Plan allowing shareholders to invest up to A$30,000 at $1.94 per share, sweetened by free-attaching options exercisable at $3.40 each.

Uscom Limited has struck a deal to sell its entire business to Singapore-based AXO Medtech VCC for $2.59 million, aiming to unlock capital for growth under new ownership. Shareholder approval is the next critical step before the transaction can proceed.

Australian Vanadium Limited has locked in a US$10 million secured loan from major shareholder RCF to advance its flagship vanadium project and prepare for a significant government battery storage tender.

Anteris Technologies has gained shareholder approval for an ASX waiver allowing flexible capital raising and updated its PARADIGM trial timeline, now set to begin patient enrolment in Q4 2025 after addressing FDA requests.

Amplitude Energy has launched the retail component of its fully underwritten entitlement offer, aiming to raise approximately A$20 million to support key growth projects including the expansion of the East Coast Supply Project and the potential restart of Patricia Baleen.

Locksley Resources has completed its second tranche placement with Tribeca, significantly strengthening its cash reserves to support its U.S. mine-to-market ambitions.

Invictus Energy has responded to an ASX inquiry about unusual trading activity, clarifying that recent price and volume changes followed a disclosed deferral of a placement tied to a strategic joint venture.

DigitalX Limited has appointed William Hamilton as General Manager following the resignation of Interim CEO Demetrios Christou, as the company continues its search for a permanent CEO.

Elanor Investors Group has obtained a crucial ASX waiver allowing a longer timeframe to issue securities tied to its $125 million recapitalisation with Rockworth Investment. This move addresses regulatory delays and aims to stabilise Elanor's balance sheet and reduce gearing.

Bod Science Limited has reported a notable profit turnaround for FY2025, driven by medicinal cannabis sales growth, while navigating a complex Deed of Company Arrangement and a proposed backdoor listing with Biortica Agrimed Limited.